Subcutaneous formulations of Anti-CD38 antibodies and their uses
ZA202304992BActive Publication Date: 2026-09-30JANSSEN BIOTECH INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- ZA202304992
- Authority / Receiving Office
- ZA · ZA
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2015-11-03
- Filing Date
- 2023-05-05
- Publication Date
- 2026-09-30
- Estimated Expiration
- 2043-05-05
Abstract
The present invention relates to subcutaneous formulations of anti-CD38 antibodies and their uses.
Need to check novelty before this filing date? Find Prior Art